These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 12089677)

  • 1. Radical cure of experimental cutaneous leishmaniasis by the bisphosphonate pamidronate.
    Rodriguez N; Bailey BN; Martin MB; Oldfield E; Urbina JA; Docampo R
    J Infect Dis; 2002 Jul; 186(1):138-40. PubMed ID: 12089677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo activity of perifosine against Leishmania amazonensis.
    Cabrera-Serra MG; Valladares B; Piñero JE
    Acta Trop; 2008 Oct; 108(1):20-5. PubMed ID: 18801328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of long-term treatment with pravastatin on the survival, evolution of cutaneous lesion and weight of animals infected by Leishmania amazonensis.
    Kückelhaus CS; Kückelhaus SA; Muniz-Junqueira MI
    Exp Parasitol; 2011 Mar; 127(3):658-64. PubMed ID: 21176775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leishmania major: activity of tamoxifen against experimental cutaneous leishmaniasis.
    Eissa MM; Amer EI; El Sawy SM
    Exp Parasitol; 2011 Aug; 128(4):382-90. PubMed ID: 21620834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity of physalins purified from Physalis angulata in in vitro and in vivo models of cutaneous leishmaniasis.
    Guimarães ET; Lima MS; Santos LA; Ribeiro IM; Tomassini TB; Ribeiro dos Santos R; dos Santos WL; Soares MB
    J Antimicrob Chemother; 2009 Jul; 64(1):84-7. PubMed ID: 19454526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activity, toxicity and analysis of resistance of essential oil from Chenopodium ambrosioides after intraperitoneal, oral and intralesional administration in BALB/c mice infected with Leishmania amazonensis: a preliminary study.
    Monzote L; Montalvo AM; Scull R; Miranda M; Abreu J
    Biomed Pharmacother; 2007; 61(2-3):148-53. PubMed ID: 17254746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful topical treatment of murine cutaneous leishmaniasis with a combination of paromomycin (Aminosidine) and gentamicin.
    Grogl M; Schuster BG; Ellis WY; Berman JD
    J Parasitol; 1999 Apr; 85(2):354-9. PubMed ID: 10219319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leishmania mexicana mexicana: genetic heterogeneity of mexican isolates revealed by restriction length polymorphism analysis of kinetoplast DNA.
    Berzunza-Cruz M; Bricaire G; Romero SZ; Pérez-Becker R; Saavedra-Lira E; Pérez-Montfort R; Crippa-Rossi M; Velasco-Castrejón O; Becker I
    Exp Parasitol; 2000 Aug; 95(4):277-84. PubMed ID: 11038311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of oral treatment with the essential oil from Chenopodium ambrosioides against cutaneous leishmaniasis in BALB/c mice, caused by Leishmania amazonensis.
    Monzote L; García M; Montalvo AM; Linares R; Scull R
    Forsch Komplementmed; 2009 Oct; 16(5):334-8. PubMed ID: 19887812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relapse of new world diffuse cutaneous leishmaniasis caused by Leishmania (Leishmania) mexicana after miltefosine treatment.
    Calvopina M; Gomez EA; Sindermann H; Cooper PJ; Hashiguchi Y
    Am J Trop Med Hyg; 2006 Dec; 75(6):1074-7. PubMed ID: 17172368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In-vitro and in-vivo studies on a topical formulation of sitamaquine dihydrochloride for cutaneous leishmaniasis.
    Garnier T; Brown MB; Lawrence MJ; Croft SL
    J Pharm Pharmacol; 2006 Aug; 58(8):1043-54. PubMed ID: 16872550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tamoxifen as a potential antileishmanial agent: efficacy in the treatment of Leishmania braziliensis and Leishmania chagasi infections.
    Miguel DC; Zauli-Nascimento RC; Yokoyama-Yasunaka JK; Katz S; Barbiéri CL; Uliana SR
    J Antimicrob Chemother; 2009 Feb; 63(2):365-8. PubMed ID: 19095684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glibenclamide, a blocker of K+(ATP) channels, shows antileishmanial activity in experimental murine cutaneous leishmaniasis.
    Serrano-Martín X; Payares G; Mendoza-León A
    Antimicrob Agents Chemother; 2006 Dec; 50(12):4214-6. PubMed ID: 17015627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leishmania amazonensis: effects of oral treatment with copaiba oil in mice.
    dos Santos AO; Costa MA; Ueda-Nakamura T; Dias-Filho BP; da Veiga-Júnior VF; de Souza Lima MM; Nakamura CV
    Exp Parasitol; 2011 Oct; 129(2):145-51. PubMed ID: 21771592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Thymus vulgaris (Thyme), Achillea millefolium (Yarrow) and propolis hydroalcoholic extracts versus systemic glucantime in the treatment of cutaneous leishmaniasis in balb/c mice.
    Nilforoushzadeh MA; Shirani-Bidabadi L; Zolfaghari-Baghbaderani A; Saberi S; Siadat AH; Mahmoudi M
    J Vector Borne Dis; 2008 Dec; 45(4):301-6. PubMed ID: 19248657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental treatment of cutaneous leishmaniasis with argentilactone isolated from Annona haematantha.
    Waechter AI; Ferreira ME; Fournet A; Rojas de Arias A; Nakayama H; Torres S; Hocquemiller R; Cavé A
    Planta Med; 1997 Oct; 63(5):433-5. PubMed ID: 9342948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular diagnosis of leishmaniosis in the Paraná state of southern Brazil.
    Pereira Ede F; Thomaz-Soccol V; Lima HC; Thomaz-Soccol A; de Castro EA; Mulinari-Brenner F; Queiroz-Telles F; Luz E
    Exp Dermatol; 2008 Dec; 17(12):1024-30. PubMed ID: 18637136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New World tegumentar leishmaniasis: chemotherapeutic activity of rifampicin in humans and experimental murine model.
    Do Valle TZ; Oliveira Neto MP; Schubach A; Lagrange PH; Da Costa SC
    Pathol Biol (Paris); 1995 Sep; 43(7):618-21. PubMed ID: 8570267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Miltefosine for new world cutaneous leishmaniasis.
    Soto J; Arana BA; Toledo J; Rizzo N; Vega JC; Diaz A; Luz M; Gutierrez P; Arboleda M; Berman JD; Junge K; Engel J; Sindermann H
    Clin Infect Dis; 2004 May; 38(9):1266-72. PubMed ID: 15127339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tamoxifen is effective against Leishmania and induces a rapid alkalinization of parasitophorous vacuoles harbouring Leishmania (Leishmania) amazonensis amastigotes.
    Miguel DC; Yokoyama-Yasunaka JK; Andreoli WK; Mortara RA; Uliana SR
    J Antimicrob Chemother; 2007 Sep; 60(3):526-34. PubMed ID: 17584801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.